Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda

Osteoporos Int. 2015 Apr;26(4):1445. doi: 10.1007/s00198-014-2993-x. Epub 2014 Dec 19.

Authors

K Ebina¹, J Hashimoto, K Shi, M Kashii, M Hirao, H Yoshikawa

Affiliation

¹ Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan, [email protected].

PMID: 25524021
DOI: 10.1007/s00198-014-2993-x

No abstract available

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid / drug therapy*
Bone Density Conservation Agents / administration & dosage*
Female
Humans
Male
Osteoporosis, Postmenopausal / drug therapy*
Teriparatide / administration & dosage*

Substances

Bone Density Conservation Agents
Teriparatide